ICCM (Icecure Medical) Marketable Securities: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ICCM Icecure Medical Ltd ICCM
46 GF Score
Price $3.60
GF Value $21.21
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Icecure Medical Marketable Securities?

Icecure Medical ICCM +0.14% 46 Marketable Securities is $0.00 Mil as of Mar. 2026. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.21 (Possible Value Trap). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Icecure Medical's Marketable Securities for the quarter that ended in Mar. 2026 was $0.00 Mil.

Icecure Medical's annual Marketable Securities declined from Dec. 2023 ($0.53 Mil) to Dec. 2024 ($0.00 Mil) but then stayed the same from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Icecure Medical  (NAS:ICCM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Icecure Medical Marketable Securities Related Terms

Icecure Medical Marketable Securities Historical Data

* Premium members only.

The historical data trend for Icecure Medical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icecure Medical Marketable Securities Chart

Icecure Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.53 0.00 0.00

Icecure Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 5.03 0.00 0.00
ICCM
46GF Score
Icecure Medical Ltd ICCM
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Icecure Medical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Icecure Medical (ICCM) has a Marketable Securities of $0.00 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Icecure Medical and its competitors.
Is Icecure Medical's Marketable Securities too high?
Icecure Medical's current Marketable Securities is $0.00 Mil. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's Marketable Securities compare to LFWD and IRIX?
Icecure Medical's Marketable Securities of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Icecure Medical and its competitors. Icecure Medical's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.21, compared to a current price of $3.60 — trading 83% below its estimated fair value. The current Marketable Securities is $0.00 Mil. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Icecure Medical (ICCM), the current Marketable Securities is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icecure Medical (ICCM) Overvalued in 2026?

Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued. The current stock price of $3.60 is trading 83% below its estimated GF Value™ of $21.21. GuruFocus considers Icecure Medical to be Possible Value Trap.

Key valuation signals for ICCM:

  • Marketable Securities: $0.00 Mil
  • GF Value™: $21.21 vs. price of $3.60 (83% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icecure Medical Business Description

Address 7 Haeshel Street, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score

Get the complete analysis for ICCM

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.60
Price
$21.21
GF Value